Literature DB >> 30824460

Hydroxychloroquine-induced inverse psoriasis.

Asad Ullah1, Hassan Zeb1, Zeeshan Khakwani1, Frederick T Murphy2.   

Abstract

A 65-year-old woman presented to our rheumatology clinic with pain and swelling of multiple joints of her hands. After a thorough evaluation, she was diagnosed with rheumatoid arthritis and was started on hydroxychloroquine therapy. A week later, she presented to our clinic with an acute condition and reported that after taking hydroxychloroquine for a few days she developed multiple rashes, most prominent at skin folds around her breasts, neck, axillae and buttocks. The rashes were characteristic of inverse psoriasis. Hydroxychloroquine was discontinued and the patient was started on methotrexate therapy that resulted in resolution of her rashes in a week. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  pharmacology and therapeutics; skin

Mesh:

Substances:

Year:  2019        PMID: 30824460      PMCID: PMC6398818          DOI: 10.1136/bcr-2018-224619

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

Review 2.  Drug induced psoriasis.

Authors:  Višnja Milavec-Puretić; Marko Mance; Romana Ceović; Jasna Lipozenčić
Journal:  Acta Dermatovenerol Croat       Date:  2011       Impact factor: 1.256

3.  The in vitro effect of hydroxychloroquine on skin morphology in psoriasis.

Authors:  R Wolf; A L Schiavo; M L Lombardi; F de Angelis; V Ruocco
Journal:  Int J Dermatol       Date:  1999-02       Impact factor: 2.736

Review 4.  Drug-induced psoriasis. Recognition and management.

Authors:  N Tsankov; I Angelova; J Kazandjieva
Journal:  Am J Clin Dermatol       Date:  2000 May-Jun       Impact factor: 7.403

Review 5.  Triggering psoriasis: the role of infections and medications.

Authors:  Lionel Fry; Barbara S Baker
Journal:  Clin Dermatol       Date:  2007 Nov-Dec       Impact factor: 3.541

6.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.

Authors:  Alice Gottlieb; Neil J Korman; Kenneth B Gordon; Steven R Feldman; Mark Lebwohl; John Y M Koo; Abby S Van Voorhees; Craig A Elmets; Craig L Leonardi; Karl R Beutner; Reva Bhushan; Alan Menter
Journal:  J Am Acad Dermatol       Date:  2008-05       Impact factor: 11.527

7.  Plaquenil-induced erythroderma.

Authors:  G A Slagel; W D James
Journal:  J Am Acad Dermatol       Date:  1985-05       Impact factor: 11.527

Review 8.  Psoriasis: classical and emerging comorbidities.

Authors:  Maria de Fátima Santos Paim de Oliveira; Bruno de Oliveira Rocha; Gleison Vieira Duarte
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

9.  Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn's Disease.

Authors:  Evan Darwin; Amar Deshpande; Hadar Lev-Tov
Journal:  ACG Case Rep J       Date:  2018-06-20
  9 in total
  4 in total

Review 1.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

2.  Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.

Authors:  Muskaan Sachdeva; Asfandyar Mufti; Khalad Maliyar; Yuliya Lytvyn; Jensen Yeung
Journal:  J Am Acad Dermatol       Date:  2020-05-19       Impact factor: 11.527

3.  Covid-19 and exacerbation of psoriasis.

Authors:  Resat Ozaras; Ahmet Berk; Dilek Hasman Ucar; Habibe Duman; Fatma Kaya; Huseyin Mutlu
Journal:  Dermatol Ther       Date:  2020-06-02       Impact factor: 2.851

Review 4.  Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.

Authors:  Antonio Martinez-Lopez; Carlos Cuenca-Barrales; Trinidad Montero-Vilchez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Am Acad Dermatol       Date:  2020-08-07       Impact factor: 11.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.